ArticleMicrobiome research reports2025

Profiling the gut and oral microbiota of hormone receptor-positive, HER2-negative metastatic breast cancer patients receiving pembrolizumab and eribulin.

Nancy My Teng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.